The Valley Desk

NCT05987332 · Interventional trial

IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma

Overall registry status Active not recruiting

Phase 2 · Phase 3

Conditions Metastatic Uveal Melanoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov